Literature DB >> 27960171

Are Basophils and Mast Cells Masters in HIV Infection?

Gianni Marone1, Gilda Varricchi, Stefania Loffredo, Maria Rosaria Galdiero, Felice Rivellese, Amato de Paulis.   

Abstract

The World Health Organization AIDS epidemic update estimates that more than 37 million people are living with HIV infection. Despite the unprecedented success of antiretroviral treatments, significant challenges remain in the fight against HIV. In particular, how uninfected cells capture HIV and transmit virions to target cells remains an unanswered question. Tissue mast cells and peripheral blood basophils can be exposed to virions or HIV products during infection. Several HIV proteins (i.e., envelope glycoproteins gp120 and gp41, Tat, and Nef) can interact with distinct surface receptors expressed by human basophils and mast cells and modulate their functional responses at different levels. Additionally, several groups have provided evidence that human mast cells can be infected in vitro, as well as in vivo, by certain strains of HIV. Recently, it has been demonstrated that basophils purified from healthy donors and intestinal mast cells can efficiently capture HIV on their cell surface and, cocultured with CD4+ T cells, they can transfer the virus to the cocultured cells leading to infection. Direct contact between human basophils or intestinal mast cells and CD4+ T cells can mediate viral trans-infection of T cells through the formation of viral synapses. Thus, basophils and mast cells can provide a cellular basis for capturing and then spreading viruses throughout the body. Collectively, these findings suggest that human basophils and mast cells play a complex and possibly distinct role in HIV infection, warranting further investigations.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27960171     DOI: 10.1159/000452889

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  7 in total

Review 1.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

2.  Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells.

Authors:  Remo Poto; Vincenzo Patella; Gjada Criscuolo; Gianni Marone; Enrico Coscioni; Gilda Varricchi
Journal:  Clin Exp Med       Date:  2022-07-25       Impact factor: 5.057

3.  IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells.

Authors:  Remo Poto; Isabella Quinti; Gianni Marone; Maurizio Taglialatela; Amato de Paulis; Vincenzo Casolaro; Gilda Varricchi
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

4.  Differential Effects of Alarmins on Human and Mouse Basophils.

Authors:  Adriana R Gambardella; Remo Poto; Valentina Tirelli; John T Schroeder; Gianni Marone; Fabrizio Mattei; Gilda Varricchi; Giovanna Schiavoni
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 5.  Mast Cells in Early Rheumatoid Arthritis.

Authors:  Felice Rivellese; Francesca Wanda Rossi; Maria Rosaria Galdiero; Costantino Pitzalis; Amato de Paulis
Journal:  Int J Mol Sci       Date:  2019-04-25       Impact factor: 5.923

6.  An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa.

Authors:  Partson Tinarwo; Temesgen Zewotir; Nonhlanhla Yende-Zuma; Nigel J Garrett; Delia North
Journal:  Infect Dis Ther       Date:  2019-02-12

7.  IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors.

Authors:  Leonardo Cristinziano; Remo Poto; Gjada Criscuolo; Anne Lise Ferrara; Maria Rosaria Galdiero; Luca Modestino; Stefania Loffredo; Amato de Paulis; Gianni Marone; Giuseppe Spadaro; Gilda Varricchi
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.